๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide โ—† The โ‚ฌ100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany โ—† Ireland's โ‚ฌ93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact โ—† The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery โ—† GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons โ—† Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing โ—† Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines โ—† Trumpโ€™s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications โ—† Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide โ—† The โ‚ฌ100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany โ—† Ireland's โ‚ฌ93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact โ—† The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery โ—† GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons โ—† Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing โ—† Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines โ—† Trumpโ€™s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications โ—†
Updated 04 Jul 2026 ยท HPRA open data

Thiotepa - Medicines in Ireland

8 authorised products containing Thiotepa, from the HPRA register.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0โ€“9
Showing 8 authorised medicines
MedicineActive substanceLicence holderStatus
TEPADINA 100 mg powder for concentrate for solution for infusion
EU/1/10/622/002
Thiotepa Adienne S.r.l. โ€”
TEPADINA 15 mg powder for concentrate for solution for infusion
EU/1/10/622/001
Thiotepa Adienne S.r.l. โ€”
TEPADINA 200 mg powder and solvent for solution for infusion
EU/1/10/622/004
Thiotepa Adienne S.r.l. S.U. โ€”
TEPADINA 400 mg powder and solvent for solution for infusion
EU/1/10/622/003
Thiotepa Adienne S.r.l. S.U. โ€”
Thiotepa Fresenius Kabi 100 mg powder for concentrate for solution for infusion
PA2059/079/002
Thiotepa Fresenius Kabi Deutschland GmbH Not marketed
Thiotepa Fresenius Kabi 15 mg powder for concentrate for solution for infusion
PA2059/079/001
Thiotepa Fresenius Kabi Deutschland GmbH Not marketed
Thiotepa Riemser 100 mg powder for concentrate for solution for infusion
EU/1/21/1536/002
Thiotepa Esteve Pharmaceuticals GmbH โ€”
Thiotepa Riemser 15 mg powder for concentrate for solution for infusion
EU/1/21/1536/001
Thiotepa Esteve Pharmaceuticals GmbH โ€”
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 14 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (โ€œAuthorised or Transfer Pending Productsโ€), licensed CC BY 4.0, refreshed daily. Regulatory information only โ€” not medical advice.